Jennison Associates’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-134,757
| Closed | -$830K | – | 693 |
|
|
2021
Q2 | $830K | Sell |
134,757
-36,703
| -21% | -$226K | ﹤0.01% | 649 |
|
|
2021
Q1 | $775K | Buy |
171,460
+23,989
| +16% | +$108K | ﹤0.01% | 640 |
|
|
2020
Q4 | $885K | Buy |
+147,471
| New | +$885K | ﹤0.01% | 583 |
|
|
2018
Q3 | – | Sell |
-68,791
| Closed | -$410K | – | 676 |
|
|
2018
Q2 | $410K | Buy |
68,791
+28,520
| +71% | +$170K | ﹤0.01% | 633 |
|
|
2018
Q1 | $235K | Buy |
+40,271
| New | +$235K | ﹤0.01% | 642 |
|
|
2016
Q4 | – | Sell |
-66,022
| Closed | -$529K | – | 813 |
|
|
2016
Q3 | $529K | Sell |
66,022
-3,867
| -6% | -$31K | ﹤0.01% | 600 |
|
|
2016
Q2 | $631K | Sell |
69,889
-1,131,504
| -94% | -$10.2M | ﹤0.01% | 572 |
|
|
2016
Q1 | $9.7M | Buy |
1,201,393
+434,249
| +57% | +$3.5M | 0.01% | 457 |
|
|
2015
Q4 | $8.29M | Sell |
767,144
-320,506
| -29% | -$3.46M | 0.01% | 482 |
|
|
2015
Q3 | $8.82M | Sell |
1,087,650
-1,753,598
| -62% | -$14.2M | 0.01% | 508 |
|
|
2015
Q2 | $68.8M | Sell |
2,841,248
-187,694
| -6% | -$4.54M | 0.06% | 273 |
|
|
2015
Q1 | $128M | Sell |
3,028,942
-56,885
| -2% | -$2.39M | 0.12% | 172 |
|
|
2014
Q4 | $104M | Sell |
3,085,827
-86,843
| -3% | -$2.93M | 0.1% | 203 |
|
|
2014
Q3 | $77.7M | Buy |
3,172,670
+86,738
| +3% | +$2.13M | 0.07% | 244 |
|
|
2014
Q2 | $90.7M | Buy |
3,085,932
+68,586
| +2% | +$2.02M | 0.08% | 221 |
|
|
2014
Q1 | $133M | Buy |
3,017,346
+326,598
| +12% | +$14.4M | 0.13% | 157 |
|
|
2013
Q4 | $103M | Sell |
2,690,748
-679,712
| -20% | -$26M | 0.1% | 188 |
|
|
2013
Q3 | $73.9M | Sell |
3,370,460
-203,567
| -6% | -$4.47M | 0.08% | 230 |
|
|
2013
Q2 | $62.4M | Buy |
+3,574,027
| New | +$62.4M | 0.07% | 252 |
|